...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phase
【24h】

Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phase

机译:枸杞子提取物对后期失代偿期糖尿病膀胱功能障碍小鼠模型的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This study aimed to elucidate the effects and mechanisms of Radix Linderae (RL) extracts on a mouse model of diabetic bladder dysfunction (DBD), especially on later decompensated phase. Male C57BL/6J mice were intraperitoneally injected with streptozotocin (STZ) after 4?weeks of high-fat diet (HFD) feeding. DBD mouse models (later decompensated phase) were developed by 12-weeks persistent hyperglycemia and then treated with RL extracts for 4?weeks. During administration, the fasting blood glucose (FBG) test was performed once a week. Four weeks later, oral glucose tolerance test (OGTT), voided stain on paper (VSOP), and urodynamic alteration were explored. We also performed haematoxylin and eosin (H&E) and Masson’s trichrome staining to observe the histology of the bladder. Then, the contractile responses to α, β-methylene ATP, capsaicin (CAP), KCl and carbachol were measured. Moreover, qPCR assay was performed to analyse the bladder gene expression levels of M3 receptors and TRPV1. The diabetic mice exhibited higher FBG, OGTT and urine production, and no substantial alteration was observed after RL treatment. Urodynamic test showed the maximum bladder capacity (MBC), residual volume (RV) and bladder compliance (BC), as well as the decrement of voided efficiency (VE) and micturition volume (MV), remarkably increased in the DBD mice. Furthermore, RL treatment significant improved urodynamic urination, with lower MBC, RV, and, BC, as well as higher VE and MV, as compared with the model groups. The wall thickness of the bladder and the ratio of smooth muscle/collagen remarkably increased, and RL could effectively attenuate the pathological change. The response of bladder strips to the stimulus was also reduced in the DBD mice, and RL treatment markedly increased the contraction. Furthermore, the gene expression levels of M3 receptors and TRPV1 were down-regulated in the bladders of the diabetic mice, whereas RL treatment retrieved those gene expression levels. RL extracts can improve the bladder voiding functions of the DBD model mice in later decompensated phase, and underlying mechanisms was associated with mediating the gene expression of M3 receptors and TRPV1 in the bladder instead of improving blood sugar levels.
机译:这项研究旨在阐明林丹提取物对糖尿病性膀胱功能障碍(DBD)小鼠模型的作用及其机制,尤其是在后来的失代偿期。在高脂饮食(HFD)喂养4周后,对雄性C57BL / 6J小鼠腹膜内注射链脲佐菌素(STZ)。通过持续12周的高血糖症发展出DBD小鼠模型(后代失代偿期),然后用RL提取物治疗4周。给药期间,每周进行一次空腹血糖(FBG)测试。四周后,研究了口服葡萄糖耐量测试(OGTT),纸上的空洞染色(VSOP)和尿动力学改变。我们还进行了苏木精和曙红(H&E)以及Masson的三色染色以观察膀胱的组织学。然后,测量对α,β-亚甲基ATP,辣椒素(CAP),氯化钾和卡巴胆碱的收缩反应。此外,进行qPCR测定以分析M3受体和TRPV1的膀胱基因表达水平。糖尿病小鼠表现出较高的FBG,OGTT和尿液生成,并且RL处理后未观察到实质性改变。尿动力学测试显示,DBD小鼠的最大膀胱容量(MBC),残余体积(RV)和膀胱顺应性(BC)以及排尿效率(VE)和排尿量(MV)的降低显着增加。此外,与模型组相比,RL治疗显着改善了尿动力学排尿,具有较低的MBC,RV和BC,以及较高的VE和MV。膀胱壁的厚度和平滑肌/胶原蛋白的比例明显增加,而RL可以有效减轻病理变化。在DBD小鼠中,膀胱条带对刺激的反应也降低了,而RL处理显着增加了收缩。此外,在糖尿病小鼠的膀胱中,M3受体和TRPV1的基因表达水平被下调,而RL治疗恢复了那些基因表达水平。 RL提取物可以改善DBD模型小鼠在失代偿后期的膀胱排尿功能,其潜在机制与介导膀胱中M3受体和TRPV1的基因表达有关,而不是改善血糖水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号